Journal Article
Lill, C. M.,
Rengmark, A.,
Pihlstrøm, L.,
Fogh, I.,
Shatunov, A.,
Sleimane, P. M.,
Wangh, L.-S.,
Liu, T.,
Lassen, C. F.,
Meissner, E.,
Alexopoulos, P.,
Calvo, A.,
Chiol, A.,
Dizdar, N.,
Faltraco, F.,
Forsgren, L.,
Kirchheiner, J.,
Kurz, A.,
Larsen, J. P.,
Liebsch, M.,
Linder, J.,
Morrison, K. E.,
Nissbrandt, H.,
Otto, M.,
Pahnke, J.,
Partch, A.,
Restagno, G.,
Rujescu, D.,
Schnack, C.,
Shaw, C. E.,
Shaw, P. J.,
Tumani, H.,
Tysnes, O.-B.,
Valladares, O.,
Silaniac, V.,
van den Berg, L. H.,
van Rheenen, W.,
Veldink, J. H.,
Lindenberger, U.,
Steinhagen-Thiessen, E.,
SLAGEN Consortium,
Teipel, S.,
Perneczkyk, R.,
Hakonarson, H.,
Hampel, H.,
von Arnim, C. A. F.,
Olsen, J. H.,
Deerlin, V. M. V.,
Al-Chalab, A.,
Toft, M.,
Ritz, B., &
Bertram, L. (2015). The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease.
Alzheimer's & Dementia,
11(12), 1407–1416. https://doi.org/10.1016/j.jalz.2014.12.009